01 1Arch Pharmalabs Limited
02 2Dipharma Francis Srl
03 1Kalchem International inc
04 1LETCO MEDICAL, LLC
05 1Medisca Inc.
06 1Nantong Jinghua Pharmaceutical Co., Ltd.
07 1Olon SpA
08 1Pfizer Ireland Pharmaceuticals
09 1Professional Compounding Centers of America
10 1Professional Compounding Centers of America dba PCCA
11 1Spectrum Laboratory Products, Inc.
12 1Unichem Laboratories Limited, India
13 1Xenex Laboratories Inc
01 3PIROXICAM
02 10Piroxicam
03 1piroxicam
01 1Canada
02 1China
03 2India
04 3Italy
05 5U.S.A
06 2United Kingdom
NDC Package Code : 22365-114
Start Marketing Date : 2010-01-11
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (50kg/50kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 46438-0639
Start Marketing Date : 2016-09-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 46438-0053
Start Marketing Date : 1987-02-02
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 38779-0302
Start Marketing Date : 2014-08-18
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 59348-0014
Start Marketing Date : 2016-11-14
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 17337-0538
Start Marketing Date : 2017-04-05
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER ()
Marketing Category : BULK INGREDIENT
NDC Package Code : 51927-0145
Start Marketing Date : 2021-06-15
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 51927-1699
Start Marketing Date : 2013-06-20
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 49452-5476
Start Marketing Date : 1996-05-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 53747-044
Start Marketing Date : 2014-03-28
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Piroxicam manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Piroxicam, including repackagers and relabelers. The FDA regulates Piroxicam manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Piroxicam API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Piroxicam manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Piroxicam supplier is an individual or a company that provides Piroxicam active pharmaceutical ingredient (API) or Piroxicam finished formulations upon request. The Piroxicam suppliers may include Piroxicam API manufacturers, exporters, distributors and traders.
click here to find a list of Piroxicam suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Piroxicam as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Piroxicam API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Piroxicam as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Piroxicam and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Piroxicam NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Piroxicam suppliers with NDC on PharmaCompass.
We have 12 companies offering Piroxicam
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
